ZA961652B - Prokinetic oxadiazoles. - Google Patents

Prokinetic oxadiazoles.

Info

Publication number
ZA961652B
ZA961652B ZA9601652A ZA961652A ZA961652B ZA 961652 B ZA961652 B ZA 961652B ZA 9601652 A ZA9601652 A ZA 9601652A ZA 961652 A ZA961652 A ZA 961652A ZA 961652 B ZA961652 B ZA 961652B
Authority
ZA
South Africa
Prior art keywords
prokinetic
oxadiazoles
prokinetic oxadiazoles
Prior art date
Application number
ZA9601652A
Other languages
English (en)
Inventor
Jean-Paul Rene Marie A Bosmans
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ZA961652B publication Critical patent/ZA961652B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA9601652A 1995-03-01 1996-02-29 Prokinetic oxadiazoles. ZA961652B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95200501 1995-03-01

Publications (1)

Publication Number Publication Date
ZA961652B true ZA961652B (en) 1997-09-11

Family

ID=8220055

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9601652A ZA961652B (en) 1995-03-01 1996-02-29 Prokinetic oxadiazoles.

Country Status (25)

Country Link
US (1) US5854261A (zh)
EP (1) EP0812321B1 (zh)
JP (1) JP3980056B2 (zh)
KR (1) KR100443554B1 (zh)
CN (1) CN1092656C (zh)
AR (1) AR003932A1 (zh)
AT (1) ATE384716T1 (zh)
AU (1) AU702932B2 (zh)
BR (1) BR9607316A (zh)
CA (1) CA2212893C (zh)
CZ (1) CZ286992B6 (zh)
DE (1) DE69637412T2 (zh)
EA (1) EA001084B1 (zh)
ES (1) ES2301166T3 (zh)
FI (1) FI973562A0 (zh)
HU (1) HUP9702395A3 (zh)
IL (1) IL117315A (zh)
MY (1) MY113584A (zh)
NO (1) NO309425B1 (zh)
NZ (1) NZ301699A (zh)
PL (1) PL183712B1 (zh)
TR (1) TR199700876T1 (zh)
TW (1) TW360653B (zh)
WO (1) WO1996026937A1 (zh)
ZA (1) ZA961652B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9603755D0 (en) * 1996-02-22 1996-04-24 Pfizer Ltd Therapeutic agents
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
US7332508B2 (en) * 2002-12-18 2008-02-19 Novo Nordisk A/S Substituted homopiperidine, piperidine or pyrrolidine derivatives
GB0910667D0 (en) * 2009-06-19 2009-08-05 Glaxo Wellcome Mfg Pte Ltd Novel compounds
PT2758394E (pt) * 2011-09-19 2015-04-22 Suven Life Sciences Ltd Compostos heteroarilo como ligandos de recetores 5-ht4
CN117777121A (zh) * 2016-10-24 2024-03-29 詹森药业有限公司 化合物及其用途
US11873298B2 (en) 2017-10-24 2024-01-16 Janssen Pharmaceutica Nv Compounds and uses thereof
SG11202108079RA (en) 2019-01-24 2021-08-30 Yumanity Therapeutics Inc Compounds and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
AU2363492A (en) * 1991-08-03 1993-03-02 Smithkline Beecham Plc 5-ht4 receptor antagonists
GB9202797D0 (en) * 1992-02-11 1992-03-25 Milsom Jonathan Glazed units
EP0664805A1 (en) * 1992-10-13 1995-08-02 Smithkline Beecham Plc Heterocyclic -esters or -amides used as 5-ht 4? receptor antagonists
MX9306311A (es) * 1992-10-13 1994-04-29 Smithkline Beecham Plc Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
KR950704328A (ko) * 1992-11-05 1995-11-17 데이비드 로버츠 5-HT₄ 수용체 길항제로서의 피페리딘 유도체(Piperidine Derivatives as 5-HT₄ Receptor Antagonists)
JPH06157518A (ja) * 1992-11-27 1994-06-03 Yamanouchi Pharmaceut Co Ltd 新規なオキサジアゾール誘導体又はその塩
AU6856094A (en) * 1994-06-01 1995-12-21 Yamanouchi Pharmaceutical Co., Ltd. Oxadiazole derivative and medicinal composition thereof

Also Published As

Publication number Publication date
DE69637412D1 (de) 2008-03-13
US5854261A (en) 1998-12-29
NZ301699A (en) 1998-02-26
TR199700876T1 (xx) 1998-02-21
NO309425B1 (no) 2001-01-29
KR100443554B1 (ko) 2004-10-06
FI973562A (fi) 1997-08-29
EA001084B1 (ru) 2000-10-30
CZ286992B6 (en) 2000-08-16
AR003932A1 (es) 1998-09-30
ATE384716T1 (de) 2008-02-15
TW360653B (en) 1999-06-11
IL117315A0 (en) 1996-06-18
CA2212893A1 (en) 1996-09-06
JPH11501021A (ja) 1999-01-26
EP0812321A1 (en) 1997-12-17
NO973808D0 (no) 1997-08-19
EA199700205A1 (ru) 1998-02-26
ES2301166T3 (es) 2008-06-16
CN1092656C (zh) 2002-10-16
DE69637412T2 (de) 2009-01-22
PL322019A1 (en) 1998-01-05
IL117315A (en) 2000-07-26
EP0812321B1 (en) 2008-01-23
PL183712B1 (pl) 2002-07-31
KR19980702304A (ko) 1998-07-15
AU702932B2 (en) 1999-03-11
CZ272397A3 (cs) 1998-02-18
NO973808L (no) 1997-08-19
HUP9702395A2 (hu) 1999-09-28
MX9706622A (es) 1997-11-29
CA2212893C (en) 2007-01-16
WO1996026937A1 (en) 1996-09-06
FI973562A0 (fi) 1997-08-29
MY113584A (en) 2002-04-30
BR9607316A (pt) 1997-12-30
AU4718896A (en) 1996-09-18
CN1177352A (zh) 1998-03-25
JP3980056B2 (ja) 2007-09-19
HUP9702395A3 (en) 1999-10-28

Similar Documents

Publication Publication Date Title
ZA967315B (en) Biphenylamides.
MX213417B (es) Fenilpiridazinonas.
ZA966777B (en) Inhaler.
ZA9610858B (en) Heteroclyclic compounds.
ZA964468B (en) Triazolylmethyl-cyclopentanols.
ZA961955B (en) Indazolecarboxamides.
EP0664969A3 (de) Skischuh.
DE69610844D1 (en) Hydroformylierungsverfahren.
GR960100066A (en) Entertainment machines.
EP0682403A4 (en) MICROMOTOR.
ZA961652B (en) Prokinetic oxadiazoles.
ZA966399B (en) Endothelin-receptor-antagonists.
EP0684299A3 (de) Dihydrofarnesal.
ZA964560B (en) Anit-viral compounds.
ZA966750B (en) Halogenobenzimidazoles.
ZA966933B (en) Endothelin-receptor-antagonists.
ZA967314B (en) Carbamoylcarboxamides.
GR3034943T3 (en) Medrogestrone.
EP0672364A3 (de) Skischuh.
EP0671133A3 (de) Skischuh.
ZA969560B (en) Substituted 1-methyl-3-phenylpyrazoles.
GR950200082U (en) Board-game.
ZA97809B (en) Skinktuit en houer daarmee toegerus.
ZA969780B (en) Cyclopeptolides.
GR2001727Y (en) Card-envelope.